Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891099580> ?p ?o ?g. }
- W2891099580 endingPage "194" @default.
- W2891099580 startingPage "181" @default.
- W2891099580 abstract "Until a recent introduction to checkpoint inhibitors, there were limited second-line chemotherapy options for urothelial carcinoma (UC) patients with disease progression after first-line, platinum-based treatment. Outcomes for patients with advanced disease over the past 30 years have highlighted a need for new and better therapy. In response to evolving interest, durvalumab (MEDI4736) was introduced as a potential treatment for advanced stages of UC. Durvalumab is a selective, high-affinity, human IgG1 kappa monoclonal antibody engineered with a triple mutation to reduce toxicity. This checkpoint inhibitor has shown promise in advanced UC and is currently the topic of much discussion in the cancer research community. This review article will explore the details surrounding durvalumab, while also giving a brief overview of additional immunotherapeutic agents utilized for UC." @default.
- W2891099580 created "2018-09-27" @default.
- W2891099580 creator A5013934919 @default.
- W2891099580 creator A5023305712 @default.
- W2891099580 creator A5048810362 @default.
- W2891099580 creator A5088863216 @default.
- W2891099580 date "2019-06-01" @default.
- W2891099580 modified "2023-10-14" @default.
- W2891099580 title "Durvalumab: a newly approved checkpoint inhibitor for the treatment of urothelial carcinoma" @default.
- W2891099580 cites W1965086052 @default.
- W2891099580 cites W1994993231 @default.
- W2891099580 cites W2021793290 @default.
- W2891099580 cites W2053011422 @default.
- W2891099580 cites W2058977958 @default.
- W2891099580 cites W2066671159 @default.
- W2891099580 cites W2095599548 @default.
- W2891099580 cites W2096785399 @default.
- W2891099580 cites W2110286249 @default.
- W2891099580 cites W2115499099 @default.
- W2891099580 cites W2123176392 @default.
- W2891099580 cites W2129456992 @default.
- W2891099580 cites W2131250428 @default.
- W2891099580 cites W2139327979 @default.
- W2891099580 cites W2144952279 @default.
- W2891099580 cites W2148562299 @default.
- W2891099580 cites W2150213518 @default.
- W2891099580 cites W2263759961 @default.
- W2891099580 cites W2312358672 @default.
- W2891099580 cites W2318856916 @default.
- W2891099580 cites W2336443029 @default.
- W2891099580 cites W2337507927 @default.
- W2891099580 cites W2339846251 @default.
- W2891099580 cites W2342094415 @default.
- W2891099580 cites W2342296008 @default.
- W2891099580 cites W2414977199 @default.
- W2891099580 cites W2469120040 @default.
- W2891099580 cites W2570618306 @default.
- W2891099580 cites W2599150633 @default.
- W2891099580 cites W2745624257 @default.
- W2891099580 cites W2753065806 @default.
- W2891099580 cites W2791290180 @default.
- W2891099580 cites W2793139049 @default.
- W2891099580 cites W2798022026 @default.
- W2891099580 cites W2801062708 @default.
- W2891099580 cites W2809595917 @default.
- W2891099580 cites W4211118805 @default.
- W2891099580 doi "https://doi.org/10.1016/j.currproblcancer.2018.08.010" @default.
- W2891099580 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30270097" @default.
- W2891099580 hasPublicationYear "2019" @default.
- W2891099580 type Work @default.
- W2891099580 sameAs 2891099580 @default.
- W2891099580 citedByCount "8" @default.
- W2891099580 countsByYear W28910995802019 @default.
- W2891099580 countsByYear W28910995802020 @default.
- W2891099580 countsByYear W28910995802021 @default.
- W2891099580 countsByYear W28910995802022 @default.
- W2891099580 crossrefType "journal-article" @default.
- W2891099580 hasAuthorship W2891099580A5013934919 @default.
- W2891099580 hasAuthorship W2891099580A5023305712 @default.
- W2891099580 hasAuthorship W2891099580A5048810362 @default.
- W2891099580 hasAuthorship W2891099580A5088863216 @default.
- W2891099580 hasConcept C121608353 @default.
- W2891099580 hasConcept C126322002 @default.
- W2891099580 hasConcept C143998085 @default.
- W2891099580 hasConcept C2777701055 @default.
- W2891099580 hasConcept C2777742743 @default.
- W2891099580 hasConcept C2780057760 @default.
- W2891099580 hasConcept C2780352672 @default.
- W2891099580 hasConcept C2911057145 @default.
- W2891099580 hasConcept C3019882237 @default.
- W2891099580 hasConcept C3020745361 @default.
- W2891099580 hasConcept C502942594 @default.
- W2891099580 hasConcept C71924100 @default.
- W2891099580 hasConceptScore W2891099580C121608353 @default.
- W2891099580 hasConceptScore W2891099580C126322002 @default.
- W2891099580 hasConceptScore W2891099580C143998085 @default.
- W2891099580 hasConceptScore W2891099580C2777701055 @default.
- W2891099580 hasConceptScore W2891099580C2777742743 @default.
- W2891099580 hasConceptScore W2891099580C2780057760 @default.
- W2891099580 hasConceptScore W2891099580C2780352672 @default.
- W2891099580 hasConceptScore W2891099580C2911057145 @default.
- W2891099580 hasConceptScore W2891099580C3019882237 @default.
- W2891099580 hasConceptScore W2891099580C3020745361 @default.
- W2891099580 hasConceptScore W2891099580C502942594 @default.
- W2891099580 hasConceptScore W2891099580C71924100 @default.
- W2891099580 hasIssue "3" @default.
- W2891099580 hasLocation W28910995801 @default.
- W2891099580 hasLocation W28910995802 @default.
- W2891099580 hasOpenAccess W2891099580 @default.
- W2891099580 hasPrimaryLocation W28910995801 @default.
- W2891099580 hasRelatedWork W1970664244 @default.
- W2891099580 hasRelatedWork W2584071843 @default.
- W2891099580 hasRelatedWork W2774605139 @default.
- W2891099580 hasRelatedWork W2803892654 @default.
- W2891099580 hasRelatedWork W2904110710 @default.
- W2891099580 hasRelatedWork W2923986778 @default.
- W2891099580 hasRelatedWork W2947133393 @default.
- W2891099580 hasRelatedWork W3088334587 @default.